INTRODUCTION
The specific molecular mechanism(s) by which steroids exert control of gene expression and cell proliferation is not known. Steroids bind to their receptors which, in turn, bind to the nuclear acceptor sites within minutes after injection into an organism (1, 2) . The result of this nuclear binding is the alteration of the rates of transcription of specific genes (1, (3) (4) (5) . Active steroid receptors 0888-8809/89/0991 -1001 $02.00/0 Molecular Endocrinology Copyright © 1989 by The Endocrine Society can also regulate gene expression by regulating the rates of degradation of specific mRNAs (5-7) and protein synthesis and processing (1) . These steroid-induced changes in the mRNA levels of specific genes occur at both early (15-20 min) and late (2-6 h) periods post injection, and their magnitude and timing is specific for both the hormone and the particular target cell (1, (3) (4) (5) .
A few steroid-sensitive genes have been shown to increase their steady state mRNA levels within 15 min after steroid administration. Examples of such early genes are those of the mouse mammary tumor virus (8) , the early induced genes of rat uterus (9, 10) , and the pS2 gene of human breast cancer cell line MCF-7 (11) . However, the vast majority of studies of the molecular mechanisms by which steroid hormones regulate genetic expression involved late genes whose transcription rates and mRNA levels are not measurably altered until 2 or more hours after hormone injection. Good examples of such late genes in the avian oviduct are the egg white protein genes, e.g. ovalbumin, ovomucoid, and lysozyme (4, (12) (13) (14) (15) . There is a 2-to 3-h lag period between the time steroids are administered to estrogen-withdrawn chickens, and the detectable significant increases in the rate of transcription and mRNA levels for these genes. Other examples of late genes include glucocorticoid induction of the rat hepatic a 2u -globulin gene (16) , and estradiol induction of the liver vitellogenin gene (17) whereby the significant increases in transcription and mRNA levels of these genes occurring 90 min or longer after steroid administration.
Early studies using nuclear run-off transcriptional analyses to assess changes in steroid-regulated RNA polymerase II activities have shown two distinct phases of increases in transcriptional activity, with a sharp peak occurring immediately after steroid administration (early response), and a broader peak occurring over the period between 2 and 12 h after steroid administration (late response) (14, 18) . The timing of the above described early and late transcriptional responses to ste-roids coincides, respectively, with these two peaks of steroid-induced RNA polymerase II activity. These data support the early and late gene response model, which encompasses a more general, biphasic response of genetic activity to steroid hormone action,. The large interval of time which elapses between steroid administration and the measurable changes in transcription of the early and late genes suggests that the transcriptional response to steroids is mediated by two (or more) related but distinct mechanisms.
This laboratory has attempted to identify rapidly regulated, steroid-sensitive genes in the avian oviduct model that code for protein products which, functioning as regulatory factors, mediate the steroid regulation of the late responding genes. Emphasis was placed on certain protooncogenes whose protein products are found in the cell nucleus and suspected of having gene regulatory functions. It was recently reported by this laboratory that c-myc mRNA concentration in the avian oviduct began to decrease within 5 min after administration of progesterone to estrogen-primed chickens, reaching a minimum of 20% of control values at about 30 min, and returning to the control mRNA level by 4 h post injection (19) . This effect of progesterone on cmyc mRNA levels was found to be tissue specific and dose dependent. Progesterone was found to also reduce c-myc mRNA concentration in oviducts of estrogen-withdrawn chickens with the same rapid kinetics observed in estrogen-stimulated chicken oviducts (Fink, K. L, T. C. Spelsberg, unpublished data). Since the avian oviduct contains functional glucocorticoid receptors (20) , and since the delayed response associated with glucocorticoid induction of egg white protein gene transcription is similar to that for progesterone induction of these same genes (21) , the effect of the glucocorticoid dexamethasone (DEX) on oviduct c-myc mRNA levels was investigated.
This paper describes a rapid, tissue-specific decrease in c-myc mRNA concentration, induced by glucocorticoids, in the oviducts of both estrogen-stimulated and estrogen-withdrawn chickens. In the same animals, glucocorticoid treatment causes a rapid increase in liver c-myc mRNA levels. The data presented here suggests that the control of the growth of the avian oviduct tissue by steroid hormones may involve direct hormonal regulation of oviduct c-myc protooncogene expression.
RESULTS
In order to determine the interval of DEX regulation of oviduct c-myc mRNA levels in both diethylstilbestrol (DES)-stimulated and DES-withdrawn chickens, pairs of animals were injected with 0.5 mg DEX and killed at varying time points over a 4-h period. The oviducts, livers, and spleens were quickly removed and frozen on dry ice. The total oviduct RNAs were isolated from the frozen tissues within 2 weeks of storage, and the relative concentrations of c-myc mRNAs were determined by Northern blot analysis using 32 P-labeled vmyc cDNA as hybridization probe. Figure 1 Fig. 1 , DEX causes a rapid, reversible decrease in c-myc mRNA levels in the oviducts of DES-withdrawn chickens. Figure 2 shows that DEX causes a similar rapid decrease in c-myc mRNA levels in the oviducts of DES-stimulated chickens. Injection of vehicle (propyleneglycol) alone into both DES-stimulated and DES-withdrawn chicks resulted in only minor changes in oviduct c-myc mRNA levels (data not shown). Figures 1 and 2 also show that the concentrations of the mRNA for H2B, a constitutive gene which is not known to be regulated by steroids, are not markedly changed after injection of the animals with dexamethasone. These data support that the response of c-myc to DEX is gene specific and that the estrogen status of the animals does not affect DEXinduced changes in the c-myc mRNA levels.
To further analyze these results, the optical absorption values of the autoradiograph bands were quantified by scanning densitometry. All autoradiographs were developed so that the most concentrated bands absorbed light below the upper thresholds of the film and densitometer. The c-myc mRNA concentrations in the oviducts from both DES-primed (Fig. 3A) and DESwithdrawn (Fig. 3B ) animals displayed decreases as early as 5 min after ip injection of 0.5 mg DEX, reached a minimum value of less than 10% of the control (preinjection) level at 30 min, and then returned to approximately 50% of the control level by 4 h postinjection (Fig. 3 ). Interestingly, vehicle shows an increase in cmyc mRNA in DES-withdrawn chicks during the first 2 h while the H2B mRNA levels show minimal changes over that period (Fig. 3A) . In DES-treated animals ( Fig.  3B ) the H2B mRNA shows an early steroid-induced increase during the first 2 h. These changes in densitometric values were reproducibly demonstrated in three to five separate animal experiments and support the steroid dependency and gene specific effects of DEX on c-myc mRNA levels.
The effect of DEX dosage on c-myc mRNA concentration in oviducts of DES-withdrawn chickens was then examined by injecting various amounts of DEX and analyzing the mRNA species at 40 min after injection by Northern blotting (data not shown). Figure 4 shows densitometric values whereby the rapid reduction in cmyc mRNA concentration occurs at a dose as low as 10 >iQ DEX (30 ng/kg BW) and achieves a minimum {i.e. maximal effect) at 100 M9 DEX where a reduction of c-myc reaches 10% of that of control values. These dose-dependent changes also support the steroid requirement for the reduction in c-myc mRNA levels. The experiments were performed as described in the legend to Fig. 1 except that estrogen-stimulated oviducts were used.
The total cellular RNAs isolated from liver and spleen of DEX-treated chickens, were also analyzed to determine the tissue specificity of DEX action on the c-myc mRNA concentration. Figure 5A shows the densitometric results of [ 32 P]v-myc cDNA hybridization to a Northern blot of total avian liver RNA, isolated after injection of 500 ng DEX into DES-withdrawn chickens. An increase (150-200% of control values) in c-myc mRNA levels from liver was consistently found by 20 to 25 min after DEX injection. Interestingly, the amount of H2B mRNA is decreased after DEX treatment of the animal in liver (Fig. 5A ). As shown in Fig. 5B , when the c-myc mRNA values are normalized to the H2B mRNA values, a dramatic increase in the c-myc mRNA concentration is observed. In contrast to the rapid decline of the c-myc mRNA in the oviduct, the c-myc mRNA levels in spleen show a more gradual multiphasic decline to a minimum of 5% control at 4 h (Fig. 6 ). These tissue specific responses demonstrate that the rapid decrease in c-myc mRNA concentration observed in The animals were given increasing amounts (10 to 500 ^g) of DEX and then killed 40 min later. Northern blot analyses for both c-myc (•) and H2B (•) mRNAs was performed as described in the legend to Fig. 1 and a densitometric analyses of these blots was performed as described in the legend to Fig. 3 . Details of the methods are described in Materials and Methods. The means of values from several densitometric scans of a typical experiment are presented.
DEX treatment is enigmatic, as increased expression of c-myc in liver is associated with liver cell proliferation (22) , and glucocorticoids reportedly inhibit proliferation of liver cells (23) . Liver tissue is comprised of cell populations whose proliferations display a wide variation in sensitivity to glucocorticoids (24) . The reproducible increase in c-myc mRNA levels observed in liver after glucocorticoid administration may represent a large increase in c-myc mRNA levels in a subpopulation of cells. In any event, the DEX-induced increase in the liver c-myc mRNA levels and the rapid, clearly defined decrease of oviduct c-myc mRNA levels demonstrate the tissue-specific nature of the steroid-regulated cmyc gene expression.
The gene specific response is demonstrated by the minimal effects of DEX on H2B mRNA levels in the oviduct, liver, and spleen. It should be mentioned that the mRNA of some other control genes, actin, and tubulin, did display more pronounced changes than the H2B mRNA in response to DEX.
All measurements of chicken oviduct c-myc mRNA levels show a degree of variability. About 30 min after DEX injection, minimum values of oviduct c-myc mRNA levels range between 5% and 20% of preinjection levels. By 4 h postinjection, the c-myc mRNA levels range between 40% and 75% of preinjection levels. There is also some variability in the minimum amount of DEX needed to give partial reduction of c-myc mRNA levels.
Even the levels of the oviduct histone H2B mRNA vary ±20% during the first 4 h after DEX treatment. These variabilities in oviduct c-myc mRNA levels is probably a combination of effects from three different sources: 1) experimental methodology error, due, for example, to differences between chickens in the amount of steroid actually injected into each animal, differences in the amounts of RNA loaded per gel lane, efficiencies of transfer of mRNA to the membrane, and efficiencies in the hybridization of the 32 P-labeled probes to the membrane-bound mRNA; 2) differences in the steroid metabolism between individual chickens, and whole body disposition of the steroid which might produce differences in the relative effects on the amounts of specific mRNA species in RNA isolated from different oviducts; 3) effects of circannual rhythms which have been shown to exist for the weight, protein content, RNA polymerase II activity, and concentrations and activities of the progesterone receptor in the avian oviduct (25, 26) . The latter is probable since these studies were performed throughout the year.
A rapid increase in c-myc gene expression is one of the early events that occur when quiescent cells are induced to proliferate by mitogens and growth factors (27, 28) . The steady state c-myc mRNA levels are generally higher in proliferating cells than in quiescent or differentiating cells (29) (30) (31) (32) . proliferation in the rat uterus (33, 34) , in human breast cancer cells (35) , and in the immature chick oviduct (36) . In contrast, c-myc expression is rapidly reduced in association with glucocorticoid inhibition of proliferation of murine P1798 thymic lymphosarcoma cells (37) and S49 lymphoma cells (38) . We report here that glucocorticoids also inhibit c-myc expression in the spleen which probably reflects the steroids effect on lymphocyte cell proliferation. We also show that DEX reduces c-myc mRNA levels in the avian oviduct, with a magnitude and timing similar to the inhibitory effects of progesterone on oviduct c-myc expression (19) . Both glucocorticoids and progesterone are known to inhibit estrogen-induced proliferation of avian oviduct tissue (39, 40) , and progesterone promotes oviduct differentiation (41, 42) . Thus, the correlation between reduction of the oviduct and spleen c-myc gene expression induced by glucocorticoids and progesterone and the effects of these steroids on cell proliferation, suggests that a direct regulation of c-myc expression by these hormones may be one of the key events mediating steroid control of whole animal tissue proliferation.
The reason for the 2-to 3-h delay in the response to steroids by most steroid regulated structural genes, termed late genes in this paper, is not known. A goal in this laboratory has been to identify genes in the chicken oviduct which undergo rapid change in transcription rate immediately after steroid injection. Rapidly regulated oviduct genes which code for nuclear proteins with possible regulatory functions would provide a model system for analyzing the structural-functional relationships between the steroid regulations of both early and late gene expression. Support for such a model is found in the midge fly system as outlined elsewhere (1, 43, 44) . The steroid ecdysone induces the synthesis of early proteins which localize in the nucleus at the chromosomal domains of late genes (45, 46) . The discovery of early and late transcriptional responses in midge salivary glands after administration of ecdysone led to the proposal in those papers that some of the steroid-responsive early genes code for regulatory (e.g. transcription) factors which are required for the transcription of the late genes (45, 46) . Such a cascade model might account for the biphasic transcriptional response to steroids observed in higher organisms mentioned earlier in this paper (1, 14, 18) . The functions of the steroid-induced early proteins that alter expression of the late genes might include the large
scale changes in chromatin ultrastructure (47, 48) changes in DNA methylation (47) (48) (49) , changes in chromatin structure associated with the appearance of DNase I hypersensitive sites (50, 51) , and finally, the more recently reported regulation of the synthesis or activation of transcription factors (1, 52-55) .
The c-myc oncogene codes for a DNA-binding protein that concentrates in the cell nucleus (56) . While the exact mechanism as to how the c-myc protein regulates DNA replication is not known, there is evidence which suggests that this mechanism is indirect (57) and that the c-myc protein is involved in the regulation of other genes (58) (59) (60) . We have shown both in this paper and elsewhere (19) that the oviduct c-myc mRNA levels begin to decline within 5 min after injection of glucocorticoids and progestins, respectively. The action of glucocorticoids and progestins on c-myc gene expression thus supports the cascade model of steroid action as proposed previously by this laboratory (1, 43, 44) . In this model, the c-myc gene is a steroid-responsive early gene which codes for a regulatory protein that can modulate expression of the more commonly measured late structural genes after a lag period (1, 43, 44) .
Such a model could be used to address some of the major questions relating to the mechanisms of steroid hormone action such as: 1) the events occurring right after the rapid association of steroid-activated receptors with specific acceptor sites on oviduct chromatin (1, 45, 46, 61, 62) , 2) the role of the steroid response elements flanking steroid-responsive genes in binding transcription factors and other regulatory gene products (1, 43, 44, (52) (53) (54) (55) as opposed to steroid receptors (63) (64) (65) (66) (67) , and 3) the role, if any, of changes in chromatin structure and/or binding of transcription factors to the gene's promoter region induced by steroids (47-53, 68, 69) . The 5-to 10-min response of c-myc gene expression to glucocorticoids and progestins suggests that the steroid-activated receptors might interact directly with regulatory sites controlling c-myc mRNA transcription, or if the rapid action of DEX is at the level of the half-life of c-myc mRNA, then a whole new model for steroid action might have to be considered. The down-regulation of c-myc mRNA levels by agents that inhibit growth and induce cell differentiation have been shown to be regulated either at the transcriptional level or at the posttranscriptional level, or both (29, 30, 70) . Experiments to determine the mechanism(s) by which c-myc expression is inhibited by glucocorticoids and progestins are in progress.
MATERIALS AND METHODS

Pretreatment of Chickens and DEX Administration
Chickens used in these experiments were Dekalb White Leghorn pullets received as 1-day-old hatchlings from a local hatchery. At 1 week of age the animals were given daily 0.2 ml, sc injections of 1 mg DES in sesame oil. The chickens were considered fully estrogen stimulated after receiving DES 5 days/week for at least 3 weeks. Estrogen-withdrawn birds represented fully stimulated chickens withdrawn from DES for at least 3 weeks before use. DEX (Sigma, St. Louis, MO) was dissolved in propyleneglycol at various concentrations to give the desired amount to be injected in 0.2 ml, and was injected ip.
Isolation of RNA after DEX Administration
In all experiments, chickens were injected with DEX at time zero (designated 0) and a minimum of two chicks were killed by cervical dislocation at each time point. Oviducts (magnum portions), livers, and spleens were quickly excised and frozen on dry ice. Frozen tissues were stored at -7 0 C until time to isolate RNA. RNA was isolated after homogenization of 0.9 g tissue in 35 ml 6 M Guanidine-HCI, 20 ITIM Na-acetate, followed by ultracentrifugation through a cushion of 8 ml 5.7 M CSCI, 0.1 M EDTA, pH 7.0, as described previously (71) . RNA concentration was determined by UV absorption at 260 nm and using 0.04 mg/ml/U 260 nm absorbance (72) . In some experiments, RNA concentrations were confirmed by the Orcinol assay (73) . Samples of each set of the RNA preparations were first analyzed by glyoxal gel electrophoresis (74, 75) , followed by ethidium bromide staining, with visual inspection under UV illumination to detect any degradation of the RNA species. The method for the isolation of oviduct RNA resulted in little or no sample degradation. However, the RNA preparations from chicken liver and spleen occasionally displayed some degradation of the RNA species, requiring a repeat of those experiments.
RNA Electrophoresis and Transfer to Filter
Total cellular RNA (25-30 ^g from each preparation) was analyzed by glyoxal, 1 % agarose, gel electrophoresis to give a size-dependent distribution of RNA molecules (74) . One lane of each slab gel was loaded with RNA molecular size standards (BRL, Gaithersburg, MD). After electrophoresis, the gel lane was removed, stained, and photographed. A plot of log (no. of nucleotides) vs. position in the gel was made based on mobility of these size standards, and the interpolation on this plot was used to determine sizes of the mRNA bands. The RNAs were transferred from gel to Magna 66 nylon membrane (MSI, Fisher Scientific, Pittsburgh, PA) by capillary flow of 3 M NaCI, 0.3 M trisodium citrate (20x SSC) as described for transfer of DNA by Southern (74, 75) . After transfer, the membrane (i.e. the Northern blot) was marked to show the position of the wells, so that mRNA band migration distance could later be determined. The blot was air dried and then baked 2 h at 80 C under vacuum to fix the RNA to the membrane.
Hybridization Analysis of mRNA
Before the hybridization, the membrane was soaked for 5 min in 3x SSC, 0.1% (wt/wt) sodium dodecyl sulfate (SDS), then for 20 min in recently boiled 20 mM Tris, pH 8.0, and finally again for 5 min in 3x SSC, 0.1% (wt/wt) SDS. The membrane was then sealed in a bag with 15 ml freshly-made prehybridization solution [50% (vol/vol) deionized formamide, 5x Denhardt's solution (76, 77) , 3x SSC, 0.01 mg/ml polyadenosine, 0.05 mg/ml denatured salmon sperm DNA, 0.1% (wt/wt) SDS, and incubated at least 3 h in 43 C water bath with gentle agitation.
The DNA hybridization probes used were linear DNA fragments labeled to specific activity of about 10 9 cpm//Ltg using Multiprime DNA labeling kit (Amersham, Arlington Heights, IL) and [ 32 P]dCTP with a specific activity of approximately 3000 Ci/mmol (New England Nuclear Research Products, Boston, MA). The c-myc mRNA was detected with a 1560 base pair fragment of the v-myc gene of avian myelocytomatosis virus MC29 (78, 79) which contains sequences homologous to exons 2 and 3 of c-myc protooncogene, but has no homology to the c-myc exon 1. The c-myc and H2B DNA (80) probes were purchased from ONCOR (Gaithersburg, MD). All heatdenatured 32 P-labeled DNA probes were mixed with 10 ml fresh prehybridization solution to have activity of about 2 x 10 6 cpm/ml. After prehybridization, the solutions were replaced with the radiolabeled probe solution, the bags were resealed, and incubated at least 18 h in 43 C water bath with gentle agitation. In some instances, both c-myc and H2B probes were incubated simultaneously with the gel blot; in other instances, only one probe was used. After hybridization, the membranes were washed 10 min in 250 ml warm 3x SSC, 0.1% (wt/wt) SDS, then sealed in a bag with 60 ml 1 X SSC, 0.1% (wt/wt) SDS and agitated for 20 min in a 55 C water bath. This was followed by two successive 20-min washes in 60 ml 0.5x SSC, 0.1% (wt/wt) SDS at 55 C. These washes were of sufficiently high stringency that [ 32 P]-v-myc probe remained hybridized to only one mRNA species on the blot. The membranes were autoradiographed with intensifying screens for 5-12 h at -7 0 C, using Kodak X-Omat AR film (Eastman Kodak Co., Rochester, NY). Films were developed by a Kodak X-Omat M20 film processor. In order to reprobe the Northern blots with different cDNA probes, membranebound radiolabeled probes were removed by agitating the bagged membranes in 60 ml 10 IDM Tris, pH 8.0, for 6-9 h at 65 C and the membranes incubated with different radiolabeled probes as described above.
Densitometry of Autoradiograph mRNA Bands
The relative amounts of c-myc mRNA in the RNA preparations were obtained by densitometric analysis of hybridization bands in autoradiograph films. Autoradiographs were scanned with a transmittance scanning densitometer (model GS 300, Hoefer Instruments, San Francisco, CA) to give an absorbance (A) profile across each mRNA band. Analog A absorption profiles were digitized and peak areas were integrated using data analysis software (Holter GS 360 data system) with an IBM PC/XT computer (IBM Corp., Boca Raton, FL). All absorbance values which were used in these studies resided within the linear capacities of the densitometer using both standard absorbance filters as well as titrated RNA preparations which had been analyzed by Northern blots.
